780 related articles for article (PubMed ID: 12962523)
1. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
2. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
5. Three-pore model predictions of 24-hour automated peritoneal dialysis therapy using bimodal solutions.
Akonur A; Leypoldt JK
Perit Dial Int; 2011; 31(5):537-44. PubMed ID: 21632445
[TBL] [Abstract][Full Text] [Related]
6. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
Akonur A; Guest S; Sloand JA; Leypoldt JK
Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
[TBL] [Abstract][Full Text] [Related]
7. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
[TBL] [Abstract][Full Text] [Related]
8. Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.
Akonur A; Firanek CA; Gellens ME; Hutchcraft AM; Kathuria P; Sloand JA
Perit Dial Int; 2016; 36(2):188-95. PubMed ID: 26293841
[TBL] [Abstract][Full Text] [Related]
9. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
[TBL] [Abstract][Full Text] [Related]
10. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
Rippe B; Levin L
Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
[TBL] [Abstract][Full Text] [Related]
11. Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis.
Leypoldt JK; Hoff CM; Akonur A; Holmes CJ
Perit Dial Int; 2015; 35(4):428-35. PubMed ID: 24584616
[TBL] [Abstract][Full Text] [Related]
12. Icodextrin Simplifies PD Therapy by Equalizing UF and Sodium Removal Among Patient Transport Types During Long Dwells: A Modeling Study.
Akonur A; Sloand J; Davis I; Leypoldt J
Perit Dial Int; 2016; 36(1):79-84. PubMed ID: 25185017
[TBL] [Abstract][Full Text] [Related]
13. Icodextrin: an alternative peritoneal dialysis fluid.
Chhabra D; Nash K
Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
[TBL] [Abstract][Full Text] [Related]
14. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
[TBL] [Abstract][Full Text] [Related]
15. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
Qi H; Xu C; Yan H; Ma J
Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.
Wolfson M; Piraino B; Hamburger RJ; Morton AR;
Am J Kidney Dis; 2002 Nov; 40(5):1055-65. PubMed ID: 12407652
[TBL] [Abstract][Full Text] [Related]
17. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
Mistry CD; Gokal R; Peers E
Kidney Int; 1994 Aug; 46(2):496-503. PubMed ID: 7967363
[TBL] [Abstract][Full Text] [Related]
18. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
Peers E; Gokal R
Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
[TBL] [Abstract][Full Text] [Related]
19. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with icodextrin. Multicenter study].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
